The Patent Finder

Adagene Pte. Ltd.

10 applications · Updated Nov 15, 2026

Patents held now

No granted US patent is recorded under this name. The published applications below are what the record holds.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

5 pending · 1 abandoned · 4 no status recorded

Showing 1 to 10 of 10, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/110,046Activatable ANTI-CTLA4 Antibodies for Treating CancerSep 8, 2023Pending
18/855,066Anti-CD28 Antibodies and Methods of Use ThereofApr 10, 2023Pending
18/842,313Mar 6, 2023No status recorded
18/705,386ANTI-CD47 Antibodies and Methods of Use ThereofOct 27, 2022Pending
18/553,043Methods for Treating Cancer Using ANTI-CTLA4 AntibodiesMar 28, 2022Pending
18/546,246Feb 11, 2022No status recorded
18/011,801Combination Therapy Comprising ANTI-CD137 AntibodiesJun 23, 2021Abandoned
17/924,540May 13, 2021No status recorded
17/759,282Heterodimeric Proteins with FC MutationsJan 22, 2021Pending
17/612,878Jun 4, 2020No status recorded

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited